[Stellar Pharmaceuticals-KY] April 2026 Revenue 0.02 Billion (Year-on-Year Decrease of -57.1%)
Stellar Pharmaceuticals-KY announced its April 2026 revenue of NT$1.668 million, a significant decrease of 57.1% compared to the previous year. The company operates in the biotechnology and healthcare industry.
📋 Article Processing Timeline
- 📰 Published: April 1, 2026 at 09:00
- 🔍 Collected: May 12, 2026 at 08:00 (983h 0m after Published)
- 🤖 AI Analyzed: May 12, 2026 at 11:29 (3h 29m after Collected)
Company Code: 6550
Company Name: Stellar Pharmaceuticals-KY
Industry: Biotechnology and Healthcare
Data Month: 2026-04
Current Month Revenue: 1,668 thousand NT$ (0.02 billion NT$)
Year-on-Year Change: -57.1%
Keywords: Monthly Revenue, Biotechnology and Healthcare Industry.
Stellar Pharmaceuticals-KY (Stock Code: 6550) has reported its financial results for April 2026. The company, which is part of the Biotechnology and Healthcare sector, generated a revenue of NT$1.668 million for the month. This figure represents a substantial year-on-year decline of 57.1%. The keywords associated with this announcement highlight the monthly revenue performance and the company's industry focus.
Company Name: Stellar Pharmaceuticals-KY
Industry: Biotechnology and Healthcare
Data Month: 2026-04
Current Month Revenue: 1,668 thousand NT$ (0.02 billion NT$)
Year-on-Year Change: -57.1%
Keywords: Monthly Revenue, Biotechnology and Healthcare Industry.
Stellar Pharmaceuticals-KY (Stock Code: 6550) has reported its financial results for April 2026. The company, which is part of the Biotechnology and Healthcare sector, generated a revenue of NT$1.668 million for the month. This figure represents a substantial year-on-year decline of 57.1%. The keywords associated with this announcement highlight the monthly revenue performance and the company's industry focus.